Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
SAN ANTONIO, April 18, 2024 /PRNewswire/ -- Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.
- SAN ANTONIO, April 18, 2024 /PRNewswire/ -- Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.
- Texas Biomed has a team of virologists and immunologists with experience studying highly pathogenic avian influenza.
- Texas Biomed has a team of virologists and immunologists with deep experience studying influenza viruses and very recently expanded its research scope to include highly pathogenic avian influenza.
- Dr. Elsayed has been studying avian influenza for 16 years and joined Texas Biomed in 2023.